Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
This is a summary aggregated from Ars Technica. Read the complete article on the original site:
Read full article at Ars Technica